Skip to main content
Home News Page 4

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

https://otc.duke.edu/wp-content/uploads/2023/09/TVD-story-featured-image.png

Setting Rivalries Aside, University Startups Come Together to Pitch 50+ Elite Investors at Triangle Venture Day: Therapeutics 2023

The recurring event offers venture capital investors from across the country an exclusive look at therapeutics startups launching from Duke, UNC, NC State University, and the North Carolina Biotechnology Center.

Read More

https://otc.duke.edu/wp-content/uploads/2023/09/menarini-stemline-logos.png

European Commission Approves Menarini Group’s ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation

ORSERDU is based on technology licensed out of the lab of Dr. Donald McDonnell (Pharmacology and Cancer Biology, SOM).

Read More

https://otc.duke.edu/wp-content/uploads/2023/01/11B5C88A-E824-48AC-B630-1E8815D4E436.jpg

Durham-based Restor3d raises $17 million

restor3d, a Duke spinout from the lab of Prof Ken Gall (MEMS, Pratt), is also a Duke Capital Partners portfolio company.

Read More

https://otc.duke.edu/wp-content/uploads/2023/09/aspirion-acquires-infinia-ml-featured-image.png

Aspirion Acquires Infinia ML, an established leader in AI and Machine Learning

Infinia ML is a Duke artificial intelligence start-up spun out of the lab of Professor Lawrence Carin (ECE, Pratt).

Read More

https://otc.duke.edu/wp-content/uploads/2023/08/Sparta_Biomedical__Logo.jpg

Sparta Biomedical Closes an Oversubscribed Convertible Round to Advance its Breakthrough Device

Sparta Biomedical, a Duke start-up and Duke Capital Partners portfolio company, was founded around technology developed by lead inventor Professor Benjamin Wiley (Chemistry, Trinity), along with Professor Ken Gall (MEMS, Pratt), Professor Matt Becker (Chemistry,…

Read More

https://otc.duke.edu/wp-content/uploads/2023/08/pivotal-commware-logo.png

Pivotal Commware Raises $102 million Series D Round to Accelerate mmWave Wireless FWA Rollout

Pivotal Commware is a Duke start-up co-founded by Professor David Smith (ECE, Pratt).

Read More

https://otc.duke.edu/wp-content/uploads/2023/08/North-Carolina-Biotechnology-Center-NCBC.png

NCBiotech Awards $2.75 Million in Grants, Loans in Latest Quarter

Two Duke start-ups received loans & four Duke projects received Translational Research Grants. Recipients hail from across the university!

Read More

https://otc.duke.edu/wp-content/uploads/2023/08/Sparta_Biomedical__Logo.jpg

Sparta Biomedical Celebrates Prestigious Recognition in MedTech and Significant Milestone

Sparta Biomedical, a Duke start-up and Duke Capital Partners portfolio company, was founded around technology developed by lead inventor Professor Benjamin Wiley (Chemistry, Trinity), along with Professor Ken Gall (MEMS, Pratt), Professor Matt Becker (Chemistry,…

Read More

https://otc.duke.edu/wp-content/uploads/2022/09/Precision-Biosciences.jpeg

Precision BioSciences Completes Strategic Transaction with Imugene for Azer-Cel in Cancer

Precision BioSciences, a genome editing Duke spin-out, was founded by then-postdocs Jeff Smith and Derek Jantz (Biochemistry, SOM).

Read More